HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sonia Vallet Selected Research

Disease Progression

1/2022Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.
10/2018A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sonia Vallet Research Topics

Disease

35Multiple Myeloma
10/2021 - 06/2005
23Neoplasms (Cancer)
08/2021 - 04/2003
6Bone Diseases (Bone Disease)
01/2016 - 07/2009
4Neoplasm Metastasis (Metastasis)
06/2021 - 08/2010
4Bone Resorption
06/2021 - 10/2007
3Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 06/2005
3Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2011 - 05/2008
2Disease Progression
01/2022 - 10/2018
2Hypoxia (Hypoxemia)
12/2021 - 02/2016
2Breast Neoplasms (Breast Cancer)
02/2019 - 08/2015
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 06/2015
2Renal Cell Carcinoma (Grawitz Tumor)
05/2016 - 06/2015
2Osteolysis
09/2011 - 03/2010
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2003 - 09/2002
2Lymphoma (Lymphomas)
04/2003 - 09/2002
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2022
1Non-Muscle Invasive Bladder Neoplasms
07/2022
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
05/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2022
1Toxic Optic Neuropathy
10/2021
1Melanoma (Melanoma, Malignant)
08/2015
1Weight Loss (Weight Reduction)
08/2015
1Kidney Neoplasms (Kidney Cancer)
06/2015
1Autoimmune Diseases (Autoimmune Disease)
09/2011
1Polyploidy
05/2011
1Anemia
10/2010
1Thrombosis (Thrombus)
10/2010
1Hypertension (High Blood Pressure)
10/2010
1Osteoporosis
10/2010

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 02/2007
5Bortezomib (Velcade)FDA Link
06/2013 - 02/2007
4Pharmaceutical PreparationsIBA
10/2021 - 02/2014
4Biological ProductsIBA
06/2013 - 05/2008
4CytokinesIBA
12/2011 - 06/2005
4DNA (Deoxyribonucleic Acid)IBA
05/2011 - 06/2007
3Monoclonal AntibodiesIBA
12/2017 - 06/2009
3Diphosphonates (Bisphosphonates)IBA
08/2015 - 09/2009
3Thalidomide (Thalomid)FDA Link
06/2013 - 07/2008
3Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2009 - 02/2007
2Azacitidine (5 Azacytidine)FDA Link
05/2022 - 06/2007
2OsteocalcinIBA
06/2021 - 07/2009
2Abiraterone AcetateIBA
01/2017 - 06/2015
2UbiquitinIBA
02/2014 - 11/2009
2Lenalidomide (CC 5013)FDA Link
06/2013 - 07/2008
2Immunomodulating AgentsIBA
03/2012 - 07/2008
2IntegrinsIBA
12/2011 - 11/2009
2Immunoglobulin G (IgG)IBA
11/2011 - 10/2010
2TOR Serine-Threonine KinasesIBA
04/2010 - 11/2009
2MethyltransferasesIBA
11/2009 - 06/2007
2p38 Mitogen-Activated Protein KinasesIBA
05/2008 - 02/2007
2Interleukin-6 (Interleukin 6)IBA
02/2008 - 02/2007
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2021
1selinexorIBA
10/2021
1belantamab mafodotinIBA
10/2021
1SARS-CoV-2 spike proteinIBA
08/2021
1COVID-19 VaccinesIBA
08/2021
1Indicators and Reagents (Reagents)IBA
06/2021
1CollagenIBA
06/2021
1Procollagen Type IIBA
06/2021
1Drug CombinationsIBA
02/2019
1Protein Kinase InhibitorsIBA
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA
10/2018
1procollagen Type I N-terminal peptideIBA
10/2018
1elotuzumabIBA
12/2017
1daratumumabIBA
12/2017
1cabazitaxelFDA Link
01/2017
1enzalutamideIBA
01/2017
1Radium-223IBA
01/2017
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2016
1capmatinibIBA
01/2016
1AntimetabolitesIBA
08/2015
1resazurinIBA
08/2015
1Alendronate (Alendronate Sodium)FDA LinkGeneric
08/2015
15-formyl-2'-deoxyuridineIBA
08/2015
15-FdU-alendronateIBA
08/2015
1abirateroneIBA
06/2015
1Docetaxel (Taxotere)FDA Link
06/2015
1Neutralizing AntibodiesIBA
04/2013
1Anabolic AgentsIBA
12/2011
1Natalizumab (Tysabri)FDA Link
11/2011
1LigandsIBA
09/2011
1ChemokinesIBA
09/2011
1CCR1 ReceptorsIBA
09/2011
11- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA
05/2011
1Aurora Kinase AIBA
05/2011
1Histones (Histone)IBA
05/2011
1Aurora KinasesIBA
05/2011
1Aurora Kinase BIBA
05/2011
1ActRIIA-mIgG2aFc fusion proteinIBA
10/2010
1Activin Receptors (Activin Receptor)IBA
10/2010

Therapy/Procedure

8Therapeutics
10/2021 - 02/2008
6Drug Therapy (Chemotherapy)
07/2022 - 09/2002
2Castration
01/2017 - 06/2015
1Neoadjuvant Therapy
07/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
12/2017
1Immunotherapy
12/2017
1Salvage Therapy
05/2016